Nanomedicine and Nanotechnology
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
”Nanomedicine and Nanotechnology” is a new section of the peer-reviewed open access journal Pharmaceutics, which is focused on all aspects and applications of innovative nanosystems.
The main aims of this section are to highlight and collect recent progress in nanotechnology and its applications in pharmaceutical, clinical, diagnostic, environmental, and cosmetic fields.
Covered topics include the following:
- Advances in methodologies for characterization of nanocarriers
- Nanodevices and nanosensors
- Stability studies
- Development of new drug delivery systems
- Nanotoxicity
- Skin and mucosal application
- Nanotechnology in tissue engineering and regenerative nanomedicine
- Functionalization for a selective target
- Nanodelivery systems in cosmeceutical and nutraceutical field
- Nanodelivery as a strategy to improve bioavailability
- Strategies and formulations for controlled drug release
- In vivo testing
The section encourages the submission of papers including in vitro and in vivo evidence and clinical data on nanomedicine and nanotechnology fields. Authors will enjoy a high-quality reviewing process, rapid publication, and high visibility from access to a broad readership.
Review, original research papers, communications, short communications, opinions, or technical notes will be considered for publication.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Nanotechnology-Based Approaches for Enhancing Oral Administration of Drugs (Deadline: 31 March 2024)
- Nanoparticles and Their Influence on Organs through the Gut–Organ Axis: Innovations in Drug Delivery and Gut Microbiota Metabolites (Deadline: 31 March 2024)
- Nanomedicines for Nucleic Acid Delivery (Deadline: 31 March 2024)
- Biological Macromolecules and Nanoparticles Self-Assembling Carrier for Therapeutic Delivery (Deadline: 31 March 2024)
- Micro- and Nano-Emulsions as Drug Delivery Systems (Deadline: 31 March 2024)
- Advances in Parenteral Formulations (Deadline: 31 March 2024)
- The Role of Nano/Microemulsions in Drug Delivery and Controlled Release (Deadline: 10 April 2024)
- Multicomponent Nanomedicines for Photodynamic Diagnosis and Photodynamic Therapy (Deadline: 10 April 2024)
- Micro/Nanostructures and Micro/Nanodevices for Tissue Engineering and Biomedicine (Deadline: 20 April 2024)
- Lipid Nanostructures as Drug Carriers for Cancer Therapy (Deadline: 20 April 2024)
- Application of Polymeric Nanoparticles in Pulmonary Drug Delivery (Deadline: 20 April 2024)
- Metal Nanoparticles for Cancer Therapy, 2nd Edition (Deadline: 20 April 2024)
- Application of Nanocarrier Systems for the Delivery of Bioactive Natural Products and Derivatives Thereof (Deadline: 20 April 2024)
- Development of Novel Tumor-Targeting Nanoparticles, 2nd Edition (Deadline: 30 April 2024)
- Nanotechnology-Enabled Strategies to Enhance Topical Bioavailability, 3rd Edition (Deadline: 30 April 2024)
- Polymer Nanoparticles for the Delivery of Anticancer Drugs, 3rd Edition (Deadline: 30 April 2024)
- Nanotechnology-Based Pharmaceutical Treatments (Deadline: 30 April 2024)
- Smart Nanotechnology to Enhancing Drug Delivery and Bioavailability (Deadline: 30 April 2024)
- Advanced Nanomaterials for Drug Delivery (Deadline: 30 April 2024)
- Recent Advances in Nanotechnology-Based Approaches for Pharmaceutical Applications (Deadline: 30 April 2024)
- Nano-Based Drug Delivery System: Recent Developments and Future Prospects (Deadline: 30 April 2024)
- Engineering and Characterisation of Novel Nanomedicine Formulations, 2nd Edition (Deadline: 30 April 2024)
- Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 85th Birthday for His Outstanding Achievements in Advancing the Field of Dendrimers (Deadline: 30 April 2024)
- Nano-Drug Delivery Technologies for Cancer Immunotherapy (Deadline: 30 April 2024)
- Polymeric Nanoplatforms for Immunotherapy and Diagnosis (Deadline: 30 April 2024)
- Contribution of Dendrimers and Other Dendritic Polymers in Medical Nanotechnology (Deadline: 1 May 2024)
- Micro- and Nanoemulsions in Therapeutics: Advancements in Targeted Drug Delivery and Theranostic Applications (Deadline: 10 May 2024)
- Combination Approaches in Photodynamic Therapies for Cancer (Deadline: 20 May 2024)
- New Properties of Supramolecular Complexes and Drug Nanoparticles (Deadline: 20 May 2024)
- Research on the Application of Nanoparticles in Tissue Engineering (Deadline: 20 May 2024)
- Smart Nanocarriers for Drug Delivery in Cancer Therapy (Deadline: 20 May 2024)
- Recent Advances in Nanomedicine for Cancer Therapy (Deadline: 20 May 2024)
- Polymer-Based Nanoparticles for Oral Delivery of Drugs, Bioactives and Vaccines (Deadline: 20 May 2024)
- Nanoparticle-Mediated Gene Delivery to Cancer Cells (Deadline: 20 May 2024)
- Application of Nanomedicine in Immunotherapy: Recent Advances and Prospects, 2nd Edition (Deadline: 30 May 2024)
- Novel Strategies for Nanotherapeutics against Cancers (Deadline: 31 May 2024)
- Application of Nanoparticles and Dendrimers for Treating Infectious Diseases (Deadline: 31 May 2024)
- Nanoparticles for Local Drug Delivery (Deadline: 31 May 2024)
- Recent Advances in Nanoparticles for Therapy and Diagnosis in Nanomedicine (Deadline: 31 May 2024)
- Applications of Dendrimers in Biomedicine, 2nd Edition (Deadline: 31 May 2024)
- Advances in Nanocarriers for Drug Delivery and Targeting, 2nd Edition (Deadline: 10 June 2024)
- Enhancing Cancer Therapeutics: Harnessing Nanoplatforms for Mitochondria-Targeted Drug Delivery (Deadline: 15 June 2024)
- Advances in the Interaction of Nanomaterials and Biosystems (Enzymes, Proteins, Peptides) (Deadline: 20 June 2024)
- Research on New Strategies for Tumor Therapy Based on Nanostructured Materials (Deadline: 20 June 2024)
- Research on Nanomaterial Applications in Photothermal Therapy for Cancer (Deadline: 20 June 2024)
- Metal and Carbon Nanomaterials for Pharmaceutical Applications (Deadline: 20 June 2024)
- Nanoparticles for Liver Diseases Therapy (Deadline: 20 June 2024)
- Nanosystems for the Delivery of Natural Products (Deadline: 30 June 2024)
- Advances in Cancer Nanotechnology for Photodynamic and Photothermal Therapy, 2nd Edition (Deadline: 30 June 2024)
- Nanotechnology Applied in Prevention, Diagnosis and Treatment of Cancer (Deadline: 30 June 2024)
- Novel Nanomaterials for Drug Delivery and Tissue Engineering (Deadline: 30 June 2024)
- Nanotechnology-Based Drug Delivery Systems, 2nd Edition (Deadline: 30 June 2024)
- Topical Advisory Panel Members' Collection Series: Nanocarriers for Alternative Drug Delivery (Deadline: 30 June 2024)
- Responsive Polymer Nanostructured Assemblies: Activity in Cancer Therapy (Deadline: 30 June 2024)
- Biomimetic Nanoparticles for Disease Treatment and Diagnosis (Deadline: 30 June 2024)
- Quality Requirements for Nanomedicines: From Early Development to the Market (Deadline: 30 June 2024)
- Advances in Phototherapy and Sonodynamic Therapy, 2nd Edition (Deadline: 20 July 2024)
- Boosting Cancer Immunotherapy with Nanomedicines: Novel Approaches and Promising Clinical Applications (Deadline: 30 July 2024)
- Smart Nanomedicine for Cancer Diagnosis and Therapy (Deadline: 31 July 2024)
- Advances in Nanotechnology-Based Drug Delivery Systems (Deadline: 31 July 2024)
- Curcumin in Biomedical Applications, 2nd Edition (Deadline: 31 July 2024)
- Lipid-Based Nanoparticles for Drug Delivery in Cancer (Deadline: 31 July 2024)
- Photodynamic, Photothermal and Photoimmune Therapy and Other Antimicrobial Nanomedicine-Related Applications (Deadline: 31 July 2024)
- Functionalized Nanoparticles in Cancer Therapeutics, 2nd Edition (Deadline: 31 July 2024)
- Natural and/or Synthetic-Based Nanostructured Systems as Drug Delivery Platforms (Deadline: 31 July 2024)
- Nanomaterials and Its Potential in Health Concern Treatment (Deadline: 10 August 2024)
- Functional Nanomaterials for Drug Delivery and Pharmaceutical Applications (Deadline: 10 August 2024)
- Nanomedicines in Cancer Therapy (Deadline: 20 August 2024)
- Advances in Targeted Photodynamic Therapy Based on Nanotechnology (Deadline: 20 August 2024)
- Nanomaterials for Cancer Diagnosis and Treatment (Deadline: 20 August 2024)
- Recent Advances in Nanotechnology Therapeutics (Deadline: 20 August 2024)
- Nanotechnology in Drug Delivery: Achievements, Challenges, and Future Directions (Deadline: 30 August 2024)
- Targeted Nanoradiopharmaceuticals as a Molecular Approach for Theranostic Applications (Deadline: 31 August 2024)
- Nanomedicines for Overcoming Tumor Immunotherapy Tolerance (Deadline: 31 August 2024)
- Metal-Based Nanoparticles for Pharmaceutical Applications (Deadline: 31 August 2024)
- Recent Advances in Biomedical Applications of Magnetic Nanomaterials (Deadline: 31 August 2024)
- Recent Advances in Pulmonary Inhalation of Nanoformulations (Deadline: 31 August 2024)
- Advanced Nanotechnology for Combination Therapy and Diagnosis (Deadline: 10 September 2024)
- Antibacterial Applications of Novel Nanoscale Biocompounds (Deadline: 20 September 2024)
- Nanosystems and Antibody/Peptide Modified Drugs for Cancer Treatment (Deadline: 20 September 2024)
- Self-Assembled Lipid Prodrug Nanomedicines for Cancerous and Noncancerous Diseases (Deadline: 20 September 2024)
- New Nano-Systems for Imaging, Diagnostics, and Drug Delivery (Deadline: 30 September 2024)
- Editorial Board Members’ Collection Series: Chitosan in Biomedicine: Current Status, Future Perspectives and Challenges (Deadline: 30 September 2024)
- Design of Novel Nanoparticles for Enhanced Antibacterial Activity (Deadline: 30 September 2024)
- Advances in Formulation of Nanocarriers for Overcoming Biological Barriers (Deadline: 30 September 2024)
- New Nanomedicine Technologies: Drug Formulation and Drug Delivery System Aspects (Deadline: 30 September 2024)
- Editorial Board Members’ Collection Series: Image-Guided and Targeted Theranostic Platforms (Deadline: 20 October 2024)
- Nanodynamic Therapies against Cancer and Microbial Infections (Deadline: 31 October 2024)
- Nanocarrier-Based Antibacterial Agents and Formulations (Deadline: 15 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions: